Partnership with Crystallics

The Dutch company Crystallics was a pioneer in the field of solid state and under the name of Avantium Pharma (see History) developed a number of unique and proprietary technologies.  These technologies include the vertical transmission X-ray powder diffraction technology with multiwell plate analysis and the proprietary ‘shaking' method of the well plate (x,y movement) which enables a much faster analysis of the samples.  Crystallics is currently the only CRO which holds a license from the inventor to use these technologies.

These unique, proprietary technologies, together with a strong customer focus, make Crystallics a leader in solid form screening and selection, preformulation and formulation design (source: http://www.crystallics.com).

On Monday the 30th March 2015, Crystallics and Excelsus Structural Solutions have announced a cooperation agreement where Crystallics will promote ESS' synchrotron technology for solid state characterization of pharmaceutical substances and products.

Read more on http://www.crystallics.com/newsletter-march-2015